Go Pro
→ I'm giving you a space stock today. Free. (From Behind the Markets) (Ad)tc pixel Free ZLDPF Stock Alerts

Zealand Pharma A/S (ZLDPF) Short Interest Ratio & Short Volume

Zealand Pharma A/S logo
$41.99 0.00 (0.00%)
As of 09/24/2026 01:15 PM Eastern
Compare

Zealand Pharma A/S Short Interest Overview

As of September 15, 2026, Zealand Pharma A/S (ZLDPF) had a short interest of 610,956 shares sold short, representing 0.85% of the public float. This marks a 8.55% increase in short interest since the prior report. The short interest ratio (days to cover) is 238.5, meaning it would take 238.5 days of the average trading volume of 715 shares to cover all short positions.

Current Short Interest
610,956 shares
Previous Short Interest
562,836 shares
Change Vs. Previous Month
8.55%
Dollar Volume Sold Short
$26.27 million
Short Interest Ratio
238.5 Days to Cover
Last Record Date
September 15, 2026
Outstanding Shares
71,530,000 shares
Short Percent of Float
0.85%
Today's Trading Volume
100 shares
Average Trading Volume
715 shares
Today's Volume Vs. Average
14%
Short Selling Zealand Pharma A/S?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Zealand Pharma A/S and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ZLDPF Short Interest Over Time

ZLDPF Days to Cover Over Time

ZLDPF Percentage of Float Shorted Over Time

Zealand Pharma A/S Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/2026610,956 shares $26.27 million +8.6%0.9%238.47 $43.00
8/31/2026562,836 shares $26.22 million +5.6%0.8%414.76 $46.58
8/14/2026533,171 shares $28.09 million -6.5%0.7%999.99 $52.68
7/31/2026570,044 shares $26.52 million -3.4%0.8%703.76 $46.53
7/15/2026590,084 shares $26.47 million +46.7%0.8%999.99 $44.86
6/30/2026402,367 shares $17.61 million +7.5%0.6%999.99 $43.77
6/15/2026374,424 shares $16.74 million -63.8%0.5%76.04 $44.70
5/29/20261,035,563 shares $50.47 million -4.3%1.4%999.99 $48.74
5/15/20261,082,556 shares $52.94 million +37.9%1.5%702.5 $48.90
4/30/2026784,775 shares $37.54 million +57.1%1.1%418.99 $47.84
4/15/2026499,684 shares $22.80 million -11.6%0.7%97.56 $45.63
3/31/2026564,964 shares $25.26 million +47.6%0.8%999.99 $44.71
3/13/2026382,899 shares $15.70 million -1.5%0.5%25.7 $40.99
2/27/2026388,662 shares $22.15 million -30.6%0.5%256.54 $57.00
2/13/2026559,955 shares $35.75 million +3.4%0.8%123.88 $63.84
1/30/2026541,382 shares $36.42 million +3.7%0.8%299.27 $67.28
1/15/2026522,063 shares $34.08 million +4.7%0.7%327.31 $65.28
12/31/2025498,674 shares $36.34 million -24.4%0.7%330.69 $72.87
12/15/2025659,905 shares $51.95 million +3.7%0.9%999.99 $78.73
11/28/2025636,564 shares $52.87 million -14.4%0.9%999.99 $83.05
11/14/2025856,416 shares $68.94 million -32.5%1.2%546.53 $80.50
10/31/20251,267,743 shares $100.34 million -2.3%1.8%1592.64 $79.15
10/15/20251,297,400 shares $97.31 million -3.7%1.8%4324.7 $75.00
9/30/20251,347,800 shares $95.55 million +10.2%N/A4492.6 $70.89
9/15/20251,222,700 shares $82.32 million +0.2%N/A3056.8 $67.33
8/31/20251,220,000 shares $83.95 million +4.8%1.7%2440 $68.81
8/15/20251,164,300 shares $66.95 million -16.1%N/A895.6 $57.50
7/31/20251,388,200 shares $73.25 million -31.8%2.0%2313.7 $52.77
7/15/20252,034,900 shares $115.05 million +42.3%N/A4069.8 $56.54
6/30/20251,429,700 shares $81.92 million +23.1%2.0%529.5 $57.30
6/15/20251,161,600 shares $81.40 million -6.6%1.6%611.4 $70.08
5/31/20251,244,100 shares $87.65 million -4.0%1.8%3110.3 $70.45
5/15/20251,295,800 shares $78.35 million -6.9%1.8%682 $60.46
4/30/20251,391,300 shares $100.56 million +0.1%N/A927.5 $72.28
4/15/20251,390,600 shares $91.94 million +5.2%2.0%632.1 $66.12
3/31/20251,321,800 shares $99.93 million +6.5%1.9%3304.5 $75.60
3/15/20251,241,700 shares $104.92 million -31.5%1.7%344.9 $84.50
2/28/20251,811,500 shares $177.13 million +1.0%2.6%6038.3 $97.78
2/15/20251,793,300 shares $186.52 million +12.9%2.5%4483.3 $104.01
1/31/20251,588,400 shares $161.24 million +28.4%N/A794.2 $101.51
Elon’s AI Phone is coming (Ad)

Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel

See the full evidence behind Elon Musk's rumored new device.
1/15/20251,237,500 shares $117.92 million +6.1%N/A825 $95.29
12/31/20241,166,300 shares $119.38 million +39.7%N/A555.4 $102.36
12/15/2024835,100 shares $94.24 million +2.7%N/A596.5 $112.85
11/30/2024813,400 shares $84.63 million +0.1%N/A135.6 $104.05
11/15/2024812,300 shares $82.85 million -0.1%N/A290.1 $102.00
10/31/2024812,800 shares $93.47 million +0.3%N/A239.1 $115.00
10/15/2024810,600 shares $92.69 million +2.2%N/A386 $114.35
9/30/2024793,400 shares $97.19 million +5.0%N/A466.7 $122.50
9/15/2024755,300 shares $103.29 million +1.9%N/A302.1 $136.76
8/31/2024741,400 shares $93.42 million -0.1%N/A741.4 $126.00
8/15/2024741,900 shares $101.63 million -0.6%N/A570.7 $136.99
7/31/2024746,000 shares $99.23 million +21.4%N/A310.8 $133.01
7/15/2024614,500 shares $83.28 million +0.5%N/A120.5 $135.52
6/30/2024611,300 shares $79.07 million +2.8%N/A59.3 $129.35
6/15/2024594,600 shares $54.98 million +8.0%N/A198.2 $92.46
5/31/2024550,400 shares $51.18 million +16.2%N/A220.2 $92.98
5/15/2024473,700 shares $45.15 million +3.6%N/A315.8 $95.30
4/30/2024457,200 shares $41.90 million +11.6%N/A268.9 $91.65
4/15/2024409,800 shares $34.50 million +21.1%N/A102.5 $84.19
3/31/2024338,500 shares $33.85 million +8.4%N/A109.2 $100.00
3/15/2024312,400 shares $31.86 million -1.9%N/A29.5 $101.98
2/29/2024318,500 shares $30.89 million -40.2%N/A23.1 $97.00
2/15/2024532,800 shares $37.59 million -12.2%N/A409.8 $70.54
1/15/2024635,900 shares $40.79 million -10.3%N/A227.1 $64.14
12/31/2023795,700 shares $44.28 million -3.0%N/A723.4 $55.65
12/15/2023795,700 shares $41.34 million -3.0%N/A723.4 $51.95
11/30/2023820,400 shares $40.56 million -6.4%N/A1367.3 $49.44
11/15/2023890,400 shares $37.09 million +4.4%N/A4452 $41.66
10/31/2023890,400 shares $38.14 million +4.4%N/A4452 $42.84
10/15/2023852,800 shares $37.68 million -0.7%N/A8528 $44.18
9/30/2023858,400 shares $37.30 million -17.6%N/A2146 $43.46
9/15/20231,041,100 shares $43.44 million -16.9%N/A1735.2 $41.72
8/31/20231,252,100 shares $46.70 million -23.8%N/A8635.1 $37.30
8/15/20231,643,700 shares $58.10 million +3.0%N/A5479 $35.35
7/31/20231,596,100 shares $53.34 million +8.2%N/A7980.5 $33.42
7/15/20231,475,800 shares $49.97 million +23.3%N/A2951.6 $33.86
6/30/20231,196,700 shares $41.35 million +31.6%N/A3989 $34.55
6/15/2023909,700 shares $36.93 million +0.0%N/A3032.3 $40.60
5/31/2023909,400 shares $34.78 million +35.5%N/A1818.8 $38.25
5/15/2023671,300 shares $25.40 million -20.7%N/A559.4 $37.84
4/30/2023847,000 shares $28.69 million -3.9%N/A8470 $33.88
4/15/2023880,900 shares $27.40 million +3.0%N/A8809 $31.11
3/31/2023855,000 shares $29.82 million -1.4%N/A8550 $34.88
3/15/2023866,900 shares $27.75 million +36.0%N/A8669 $32.01
2/28/2023637,500 shares $19.63 million -1.9%N/A3187.5 $30.79
2/15/2023650,100 shares $19.06 million +3.2%N/A928.7 $29.32
1/31/2023630,200 shares $18.91 million -0.4%N/A3151 $30.00
1/15/2023632,600 shares $18.98 million -4.5%N/A3163 $30.00
12/30/2022662,500 shares $18.67 million -0.9%N/A1656.3 $28.18
12/15/2022668,800 shares $18.81 million -0.8%N/A2229.3 $28.12
This free guide explains options the way they should be taught (Ad)

Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade. This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan.tc pixel

Claim your free options guide and start building real trading knowledge
11/30/2022674,300 shares $18.95 million -3.8%N/A613 $28.10
11/15/2022701,000 shares $18.97 million +9.8%N/A637.3 $27.07
10/31/2022638,500 shares $16.44 million -11.0%N/A912.1 $25.75
10/15/2022717,600 shares $16.72 million -4.5%N/A3588 $23.30
9/30/2022751,500 shares $17.25 million +4.0%N/A1503 $22.95
9/15/2022722,900 shares $13.02 million +1.9%N/A7229 $18.01
8/31/2022709,300 shares $13.58 million -31.5%N/A886.6 $19.15
8/15/20221,035,900 shares $16.98 million +33.5%N/A3453 $16.39
7/31/2022775,900 shares $11.71 million +1.3%N/A0 $15.09
7/15/2022766,000 shares $11.56 million -3.3%N/A3830 $15.09
6/30/2022791,700 shares $9.37 million +0.7%N/A7917 $11.83
6/15/2022786,000 shares $9.39 million -1.3%N/A7860 $11.95
5/31/2022796,200 shares $10.91 million +222.5%N/A7962 $13.70
5/15/2022246,900 shares $2.75 million -12.1%N/A2469 $11.14
4/30/2022280,900 shares $4.35 million +1.9%N/A0 $15.50
4/15/2022275,800 shares $4.27 million +7.9%N/A2758 $15.50
3/31/2022255,700 shares $4.14 million -1.9%N/A319.6 $16.20
3/15/2022260,700 shares $3.74 million +2.5%N/A0 $14.35
2/28/2022254,300 shares $3.65 million +581.8%N/A2543 $14.35
2/15/202237,300 shares $641.56 thousand -1.6%N/A373 $17.20
1/31/202237,900 shares $873.60 thousand -13.5%N/A379 $23.05
1/15/202243,800 shares $1.01 million +11.7%N/A73 $23.05
12/31/202139,200 shares $863.97 thousand -37.3%N/A392 $22.04
12/15/202162,500 shares $1.60 million -9.2%N/A0 $25.65
11/30/202168,800 shares $1.76 million -14.5%N/A0 $25.65
11/15/202180,500 shares $2.06 million +6.6%N/A201.3 $25.65
10/29/202175,500 shares $2.39 million +1.2%N/A755 $31.65
10/15/202174,600 shares $2.21 million +16.4%N/A0 $29.65
9/30/202164,100 shares $1.90 million +105.5%N/A641 $29.65

ZLDPF Short Interest - Frequently Asked Questions

Short interest is the volume of Zealand Pharma A/S shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 610,956 shares of ZLDPF short. 0.85% of Zealand Pharma A/S's shares are currently sold short. Learn More on Zealand Pharma A/S's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZLDPF shares currently have a short interest ratio of 238.5. Learn More on Zealand Pharma A/S's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.85% of Zealand Pharma A/S's floating shares are currently sold short.

Zealand Pharma A/S saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 610,956 shares, an increase of 8.5% from the previous total of 562,836 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.85% of Zealand Pharma A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Zealand Pharma A/S: Madrigal Pharmaceuticals, Inc. (11.84%), Krystal Biotech, Inc. (12.30%), Kymera Therapeutics, Inc. (15.07%), Arrowhead Pharmaceuticals, Inc. (6.83%), Protagonist Therapeutics, Inc. (13.27%), Abivax SA Sponsored ADR (7.85%), ImmunityBio, Inc. (34.91%), TG Therapeutics, Inc. (21.62%), Vaxcyte, Inc. (11.21%), Cytokinetics, Incorporated (14.42%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.21 billion), Invesco QQQ ($46.31 billion), iShares Russell 2000 ETF ($27.98 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($9.70 billion), Canadian Natural Resources Limited ($9.42 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.53 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.79 billion), and Financial Select Sector SPDR Fund ($7.74 billion). View all of the most shorted stocks.

Short selling ZLDPF is an investing strategy that aims to generate trading profit from Zealand Pharma A/S as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Zealand Pharma A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZLDPF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZLDPF, twice per month. The most recent reporting period available is September, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ZLDPF:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for OTCMKTS:ZLDPF is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
Iran War WARNING: Something Just Changed
A powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...
Banyan Hill Publishing | Sponsoredtc pixel
Analyst nicknamed “The Prophet” issues new warning for America
Whitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...
Stansberry Research | Sponsoredtc pixel
America Can’t Afford to Lose This Race. But at What Cost?
AI spending on data centers, chips and power infrastructure is exploding, and much of it is financed with heav...
Weiss Ratings | Sponsoredtc pixel